Journal Home
Search for

Volume 20, Issue 3, Pages 328-334 (March 2010)


View previous. 7 of 24 View next.

Addition of sphingosine-1-phosphate to human oocyte culture medium decreases embryo fragmentation

Antoine HannounCorresponding Author Informationemail address, Ghina Ghaziri, Antoine Abu Musa, Tony G. Zreik, Fatiha Hajameh, Johnny Awwad

Received 7 May 2009; received in revised form 16 June 2009; accepted 19 November 2009. published online 21 January 2010.

Abstract 

Apoptosis is implicated in the fragmentation of preimplantation mammalian embryos, yet the extent of this association remains controversial. The aim of this study was to assess the ability of sphingosine-1-phosphate (S1P), a known anti-apoptotic substance, to reduce the fragmentation rate of human preimplantation embryos when added to their culture microenvironment. Mature human oocytes were inseminated using intracytoplasmic sperm injection, incubated for 3 days and evaluated for embryo quality and fragmentation by the same embryologist. Oocytes in the study group were manipulated and cultured in culture medium supplemented with S1P to a 20μmol/l concentration. A total of 46 patients donated 177 mature oocytes for the study group and 546 oocytes for the control group. The fertilization rate was significantly lower in the S1P-supplemented group (52.4% versus 67.3%; P=0.002) and the proportion of grade I embryos with less than 15% fragmentation was significantly higher in the same group (79.5% versus 53.9%; P<0.0001). Sphingosine-1-phosphate added to the culture medium of human preimplantation embryos is associated with a significantly lower fragmentation rate and hence better quality embryos. The clinical significance of these findings on reproductive outcome remains highly speculative awaiting further studies to translate this improvement in embryo quality into better pregnancy rates.

Declaration: The authors report no financial or commercial conflicts of interest.

Department of Obstetrics and Gynecology, American University of Beirut-Medical Center, PO Box 113–6044/12 B, Beirut, Lebanon

Corresponding Author InformationCorresponding author.

 Professor Antoine Hannoun is an associate professor in the American University of Beirut-Medical Center where he teaches medical students and residents in the Department of Obstetrics and Gynecology in addition to practicing medicine. His sub-specialty is in reproductive endocrinology and infertility and he set up the hospital’s successful IVF program in 1993.

PII: S1472-6483(09)00271-5

doi:10.1016/j.rbmo.2009.11.020


View previous. 7 of 24 View next.